ASN Podcast

Kidney Week 2024 on the go. Gentzon Hall, MD, PhD, FASN, Matthias Kretzler, MD, and Heather Reich, MD, PhD, discuss progress in glomerular disease research, emerging trends, and clinical challenges.

Host Tod Ibrahim is joined by Rachel Meyer, Strategic Policy Advisor to the Executive Vice President and Suzanne Watnick, ASN Policy Scholar in Residence to discuss the recent developments in the transplant policy realm.

Renowned nephrologist Ron Wald from St. Michael's Hospital dives into crucial topics surrounding kidney replacement therapy in the ICU. He discusses the latest research on dialysis initiation and patient outcomes, emphasizing the need for individualized care in acute kidney injury. Wald highlights the importance of rigorous clinical trials and alternative outcome measures beyond urea clearance. He also tackles the complexities of fluid management and ultrafiltration rates, advocating for a nuanced approach to enhance patient safety and treatment efficacy.

Hosts Tod Ibrahim and David White are joined by colleague Zach Kribs to provide an update on the status of Congressional funding legislation and ASN's advocacy priorities. This episode mainly focuses on the House Appropriations Committee.

Hosts Tod Ibrahim and David White discuss the recently released CY2025 End-Stage Renal Disease Prospective Payment System and Quality Incentive Program (ESRD PPS QIP) proposed rule and the CY2025 Medicare Physician Fee Schedule proposed rule.

In this new series, Drs. Alice Sheridan and Martina McGrath speak with guest editor Dr. Michael Emmett to discuss his editorial "Cystic Fibrosis and Hypoelectrolytemia With Metabolic Alkalosis" from nephSAP Volume 23, Number 2.

Hosts Tod Ibrahim and David White discuss the Center for Medicare and Medicaid Innovation's recently announced Increasing Organ Transplant Access (IOTA) Model proposed rule.

Hosts Tod Ibrahim and David White are joined by colleague Zach Kribs, ASN Manager of Congressional Affairs to discuss ASN's recent Capitol Hill advocacy on transplant.

David White is joined by Health Policy Scholar in Residence Dr. Suzanne Watnick and Zach Kribs to discuss the Kidney PATIENT Act of 2023- a bill that would delay the inclusion oral only drugs in the ESRD PPS.

Quality and Regulatory Affairs Associate Lauren Ahearn is joined by Congressional Affairs Manager Zach Kribs to discuss the possible March partial government shutdown as well as congressional action on the Medicare physician reimbursement cut.